H. Elliott

发表

RISK‐BENEFIT OF SPECIFIC ANTIHYPERTENSIVE REGIMENS: RELEVANCE OF METABOLIC AND HAEMODYNAMIC EFFECTS OF α1‐BLOCKERS

J. Reid, J. Curzio, H. Elliott, 1988, Clinical and experimental pharmacology & physiology.

Angiotensin II antagonists: efficacy, duration of action, comparison with other drugs

H. Elliott, 1998, Journal of Human Hypertension.

Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin.

P. Meredith, J. Reid, A. Kelman, 1988, Xenobiotica; the fate of foreign compounds in biological systems.

The influence of clinical adrenoceptor antagonism on plasma lipid profiles.

H. Elliott, 1988, Trends in pharmacological sciences.

Trough to peak ratio: current status and applicability

H. Elliott, 1998, Journal of Human Hypertension.

Risk factor modification in hypertension--success and failure.

J. Reid, J. Curzio, S. Kennedy, 1987, Journal of human hypertension.

Evidence for postjunctional vascular alpha 2-adrenoceptors in peripheral vascular regulation in man.

J. Reid, H. Elliott, 1983, Clinical science.

Adimolol, a long acting 3-adrenoceptor blocker in man prolonged 13-adrenoceptor antagonism

P. Meredith, H. Elliott, J. Reid, 2006 .

The alpha adrenoceptor antagonist properties of idazoxan in normal subjects

J. Reid, J. Vincent, C. Lawrie, 1984, Clinical pharmacology and therapeutics.

Kinetic and dynamic comparison of piretanide and furosemide

B. Whiting, H. Elliott, D. Sumner, 1978, Clinical pharmacology and therapeutics.

Clinical Pharmacology of Drugs Acting on Imidazoline and Adrenergic Receptors

J. Reid, G. Macphee, H. Elliott, 1995, Annals of the New York Academy of Sciences.

Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man.

J. Reid, C. Hamilton, I. Rodger, 1986, Clinical science.

Clinical Studies with the Potassium Channel Activator Cromakalim in Normotensive and Hypertensive Subjects

P. Meredith, J. Reid, R. Donnelly, 1990, Journal of Cardiovascular Pharmacology.

Effect of age on the responsiveness of vascular alpha-adrenoceptors in man.

J. Reid, K. McLean, H. Elliott, 1982, Journal of cardiovascular pharmacology.

Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist.

J. Reid, H. Elliott, C. Jones, 1983, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Preferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the ‘ACTION' database in patients with angina

P. Meredith, H. Elliott, P. Meredith, 2010, Journal of Human Hypertension.

The pharmacokinetics and angiotensin converting enzyme inhibition dynamics of cilazapril in essential hypertension.

P. Meredith, J. Reid, H. Elliott, 1989, British journal of clinical pharmacology.

Double‐Blind Comparison of the Cardioselective &bgr;‐Blockers Bisoprolol and Atenolol in Hypertension: The Bisoprolol International Multicenter Study (BIMS)

A. Zanchetti, J. Reid, T. Philipp, 1985, Journal of cardiovascular pharmacology.